Photo from dana-farber.org
Jul 14, 2023, 19:34
Hepatotoxicity to Ribociclib is rather common (9% g3/g4) – Dr Sarah Sammons
Hepatotoxicity to Ribociclib is rather common (9% g3/g4). I have had 4 cases now responsive only to steroids after not relenting with cessation alone. Nice case reports below. We need to study this more, seems autoimmune in some cases.
For article: Click here
Source: Dr Sarah Sammons/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 17, 2025, 06:44
Apr 17, 2025, 06:30
Apr 17, 2025, 05:47
Apr 17, 2025, 00:19
Apr 17, 2025, 00:17